Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Guelph

$17,500.00

Augmentation of a Canine Melanoma Vaccine with Immunomodulatory Antibodies

FY 2015-16

Summary
Title: Augmentation of a Canine Melanoma Vaccine with Immunomodulatory AntibodiesMelanomas are very aggressive forms of skin cancers, for which traditional chemotherapies have failed to yield effective results. As such, we are interested in testing new immune-based therapies in dogs with melanomas, eventually hoping to translate the most promising therapeutic strategies into human medicine. Cancer immunotherapy is a type of treatment used to activate the body's defense system against the cancerous cells, allowing the patients to kill their own tumour cells. The goal of my research is to develop a new vaccine to stimulate cancer-specific immune responses in dogs with naturally-occurring melanomas. The vaccine will be designed to alert the patient's immune system to the presence of a tumour. In addition to this, two antibodies will be generated, specifically for use in dogs. In combination with the vaccine, these antibodies will bind to specific targets on the surface of immune cells, to improve their ability to kill the tumour cells. During the first year of my graduate program, I will be optimizing the methods used to monitor immune responses, and supporting the development of the vaccine. In the second year, I will evaluate the safety of the antibodies and assess their potential to increase the function of vaccine-induced immune cells in dogs. We predict that this strategy will be able to improve the survival and quality of life for dogs suffering from melanomas.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
350095
Name
Au Yeung Wing Ka Amanda
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Augmentation of a Canine Melanoma Vaccine with Immunomodulatory Antibodies
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Canine; Cd8+ T Cells; Co-Stimulatory Receptors; Combination Therapies; Immunology; Immunomodulatory Antibodies; Melanoma; Tumour; Tumour Infiltrating Lymphocytes; Viral Vaccines
Abstract
Title: Augmentation of a Canine Melanoma Vaccine with Immunomodulatory AntibodiesMelanomas are very aggressive forms of skin cancers, for which traditional chemotherapies have failed to yield effective results. As such, we are interested in testing new immune-based therapies in dogs with melanomas, eventually hoping to translate the most promising therapeutic strategies into human medicine. Cancer immunotherapy is a type of treatment used to activate the body's defense system against the cancerous cells, allowing the patients to kill their own tumour cells. The goal of my research is to develop a new vaccine to stimulate cancer-specific immune responses in dogs with naturally-occurring melanomas. The vaccine will be designed to alert the patient's immune system to the presence of a tumour. In addition to this, two antibodies will be generated, specifically for use in dogs. In combination with the vaccine, these antibodies will bind to specific targets on the surface of immune cells, to improve their ability to kill the tumour cells. During the first year of my graduate program, I will be optimizing the methods used to monitor immune responses, and supporting the development of the vaccine. In the second year, I will evaluate the safety of the antibodies and assess their potential to increase the function of vaccine-induced immune cells in dogs. We predict that this strategy will be able to improve the survival and quality of life for dogs suffering from melanomas.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Au Yeung, Wing Ka Amanda
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~